Title:
THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE
Document Type and Number:
WIPO Patent Application WO/2017/111052
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a medicament for treating an autoimmune disease. The present invention pertains specifically to a therapeutic agent for an autoimmune disease such as HTLV-associated myelopathy, which contains L-arginine hydrochloride as an active ingredient.
Inventors:
TAKASHIMA HIROSHI (JP)
ARATA HITOSHI (JP)
MATSUURA EIJI (JP)
TASHIRO YUICHI (JP)
ANDO MASAHIRO (JP)
ARATA HITOSHI (JP)
MATSUURA EIJI (JP)
TASHIRO YUICHI (JP)
ANDO MASAHIRO (JP)
Application Number:
PCT/JP2016/088434
Publication Date:
June 29, 2017
Filing Date:
December 22, 2016
Export Citation:
Assignee:
UNIV KAGOSHIMA (JP)
International Classes:
A61K31/198; A61P25/00; A61P29/00; A61P31/14; A61P37/02
Foreign References:
| JPH0789862A | 1995-04-04 | |||
| JP2000184865A | 2000-07-04 |
Other References:
"Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients with HTLV-1 Associated Myelopathy (HAM", CLINICALTRIALS, NCT ID: NCT00001785, 3 March 2008 (2008-03-03), pages 1 - 5, XP055397467, Retrieved from the Internet
KOHEI OTA: "Tahatsusei Kokasho Management Handbook", December 2013 (2013-12-01), pages 82 - 90, Retrieved from the Internet [retrieved on 20170201]
YOSHIHISA YAMANO ET AL.: "Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP", JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 71, no. 5, May 2013 (2013-05-01), pages 870 - 875, ISSN: 0047-1852
KOHEI OTA: "Tahatsusei Kokasho Management Handbook", December 2013 (2013-12-01), pages 82 - 90, Retrieved from the Internet
YOSHIHISA YAMANO ET AL.: "Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP", JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 71, no. 5, May 2013 (2013-05-01), pages 870 - 875, ISSN: 0047-1852
Attorney, Agent or Firm:
HIRAKI Yusuke et al. (JP)
Download PDF: